Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Research Operations Officer fellow to join our team. 

Host

Cristina João, MD, PhD, Myeloma Lymphoma Research Group

Venue

Seminar room

The recruitment process for this call is now closed

Champalimaud Foundation is actively looking for a Research Funding Manager. If you are passionate about science and ready to be challenged daily while you help bring some of the most promising research ideas in neuroscience, behaviour, physiology and cancer into reality, this opportunity may be for you.

The meeting brought together over 200 specialists from 25 countries, representing a truly international effort to advance research and clinical practice in the field of kidney diseases associated with monoclonal gammopathies.

The scientific programme featured a rich series of sessions addressing key areas in the field, including new pathophysiological insights into monoclonal gammopathies and kidney disease, innovations in diagnostic tools and biomarkers, emerging therapeutic strategies, and the latest updates from ongoing clinical trials.

Blending in-depth lectures with guided laboratory sessions, the workshop offered a dynamic introduction to core molecular biology techniques. Participants engaged directly with methods such as RNA extraction, cDNA synthesis, PCR, restriction enzyme digestion, electrophoresis, plasmid DNA isolation, sequence analysis, and experimental design for cloning projects.

By combining expert instruction with hands-on practice, the programme not only reinforced fundamental concepts but also fostered confidence in applying these tools to real-world research challenges.

The Cell Centre is looking to expand efforts in the GMP production of cell products with a specific focus on immune-monitoring. 

The successful applicant is expected to be pivotal co-worker in the development and improvement of immune cell-based therapies for malignant diseases and the preparation of GMP compliant production of cellular products including gene-modified immune cells and monitoring of anti-cancer directed vaccination.

Host

Carlos Minutti, PhD, Immunoregulation Lab

Venue

Seminar room